TANG CAPITAL MANAGEMENT LLC
Q1 2025 13F Holdings
- Locationsan diego, CA
- Num holdings
202
- Value ($000)
$1,807,581
- Date Filed05/15/2025
- Form type13F-HR
- CIK0001232621
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q1 2025 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
TARS TARSUS PHARMACEUTICALS INC | COM | 87650L103 | $126.10 M | 7 % | 2,454,797 | ||
GLPG GALAPAGOS NV | SPON ADR | 36315X101 | $99.52 M | 6 % | 3,961,797 | ||
AUPH AURINIA PHARMACEUTICALS INC | COM | 05156V102 | $80.64 M | 5 % | 10,029,500 | ||
DVAX DYNAVAX TECHNOLOGIES CORP | COM NEW | 268158201 | $74.58 M | 4 % | 5,750,000 | ||
EOLS EVOLUS INC | COM | 30052C107 | $60.12 M | 3 % | 4,997,399 | ||
KALV KALVISTA PHARMACEUTICALS INC | COM | 483497103 | $57.03 M | 3 % | 4,941,798 | ||
IMCR IMMUNOCORE HLDGS PLC | ADS | 45258D105 | $56.84 M | 3 % | 1,915,708 | ||
MIRM MIRUM PHARMACEUTICALS INC | COM | 604749101 | $55.73 M | 3 % | 1,237,107 | ||
PTCT PTC THERAPEUTICS INC | COM | 69366J200 | $50.96 M | 3 % | 1,000,000 | ||
KINIKSA PHARMACEUTICALS INTL | ORD SHS CL A | G52694109 | $47.05 M | 3 % | 2,118,579 |
Rows Per Page
10
- 10
- 50
- 100